Rochester Enterprises Inc
Exclusive Provider Organization
2081 Business Center Dr, Suite 245, Irvine
California, 92612-1119
800-986-5164 800-986-5164
Rochester Enterprises Inc is not a DME supplier for medicare equipments and products.
Rochester Enterprises Inc is a Exclusive Provider Organization in Irvine, California. It is located at 2081 Business Center Dr, Suite 245, Irvine and it's customer support contact number is 800-986-5164. The authorized person of Rochester Enterprises Inc is Dr. Harold Carter, PHARM D who is Pharmacist In Charge of the pharmacy and his contact number is 800-986-5164. Active license number of Rochester Enterprises Inc is C0867846 for Exclusive Provider Organization in California.
Rochester Enterprises Inc is (1) An EPO is a form of PPO, in which patients must visit a caregiver that is specified on its panel of providers (is a participating provider). If a visit to an outside(not participating) provider is made the EPO offers very limited or no coverage for the medical service; (2) While similar to a PPO in that an EPO allows patients to go outside the network for care, if they do so in an EPO, they are required to pay the entire cost of care. An EPO differs from an HMO in that EPO physicians do not receive capitation but instead are reimbursed only for actual services provided; (3) An organization identical to a preferred provider organization except that persons enrolled in the plan are eligible to receive benefits only when they use the services of the contracting providers. No benefits are available when non-contracting providers are used, except in certain emergency situations.
Pharmacy Details:
Rochester Enterprises Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Rochester Enterprises Inc |
| Type: | Exclusive Provider Organization |
| Location: | 2081 Business Center Dr, Suite 245, Irvine, California, 92612-1119 |
| Phone: | 800-986-5164 |
| Fax: | 800-986-5164 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Dr. Harold Carter |
| Credentials: | PHARM D |
| Position: | Pharmacist In Charge |
| Contact Number: | 800-986-5164 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1720356264 |
| NPI Enumeration Date: | 12 Dec, 2011 |
| NPI Last Update On: | 12 Dec, 2011 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rochester Enterprises Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Exclusive Provider Organization | C0867846 | California | Primary | |
| Durable Medical Equipment & Medical Supplies | C0867846 | California | Secondary | |
| Mail Order Pharmacy | C0867846 | California | Secondary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 2081 Business Center Dr, Suite 245 Irvine, California |
| Zip: | 92612-1119 |
| Phone Number: | 800-986-5164 |
| Fax Number: | 800-986-5164 |
Patients can reach Rochester Enterprises Inc at
2081 Business Center Dr, Suite 245, Irvine, California or can
call on customer care at 800-986-5164.
Comments/ Reviews:
Read all the reviews posted for Rochester Enterprises Inc below. You may also share your own experience with Rochester Enterprises Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.